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symptoms
Abstract
Background: Depressed individuals often refuse or withdraw from help, a phenomenon termed helpnegation, which is a risk factor for poor outcomes. Most previous research has investigated psychosocial
factors including stigma as causes of low help-seeking intentions for depression, however these do not
adequately explain the problem. We hypothesised that because help-negation worsens with symptom
severity, it might be linked to important biological changes associated with depression itself. We
investigated the relative contributions of cortisol, a stress hormone linked to depression, and oxytocin, a
hormone which mediates social behaviours, alongside psychosocial factors, to help-seeking intentions
among depressed and non-depressed individuals. Methods: Morning plasma cortisol and oxytocin levels,
psychopathology, suicidal ideation, help-seeking intentions from informal sources including family and
friends, and formal sources including health professionals, and perceived social support were quantified
in 63 adults meeting DSM-5 criteria for major depressive disorder (MDD) who were not receiving any
treatment, and 60 healthy controls. Between-group analyses of variance, correlations, and hierarchical
multiple regressions were employed. Results: Help-seeking intentions were lower in depressed than
healthy participants, negatively correlated to cortisol and positively correlated to oxytocin. Cortisol
negatively, and oxytocin positively, predicted helpseeking intentions from informal but not formal sources,
after controlling for psychopathology and psychosocial factors. Conclusions: Neuroendocrine changes
associated with depression may contribute to low help-seeking from friends and family, which may have
implications for interpersonal support and outcomes. Research and clinical approaches which
incorporate biological as well as psychosocial factors may allow for more targeted and effective early
interventions to address lack of help-seeking and depression progression.
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Abstract
Background: Depressed individuals often refuse or withdraw from help, a phenomenon
termed help-negation, which is a risk factor for poor outcomes. Most previous research has
investigated psychosocial factors including stigma as causes of low help-seeking intentions
for depression, however these do not adequately explain the problem. We hypothesised that
because help-negation worsens with symptom severity, it might be linked to important
biological changes associated with depression itself. We investigated the relative
contributions of cortisol, a stress hormone linked to depression, and oxytocin, a hormone
which mediates social behaviours, alongside psychosocial factors, to help-seeking intentions
among depressed and non-depressed individuals.
Methods: Morning plasma cortisol and oxytocin levels, psychopathology, suicidal ideation,
help-seeking intentions from informal sources including family and friends, and formal
sources including health professionals, and perceived social support were quantified in 63
adults meeting DSM-5 criteria for major depressive disorder (MDD) who were not receiving
any treatment, and 60 healthy controls. Between-group analyses of variance, correlations, and
hierarchical multiple regressions were employed.
Results: Help-seeking intentions were lower in depressed than healthy participants, negatively
correlated to cortisol and positively correlated to oxytocin. Cortisol negatively, and oxytocin
positively, predicted help-seeking intentions from informal but not formal sources, after
controlling for psychopathology and psychosocial factors.
Conclusions: Neuroendocrine changes associated with depression may contribute to low helpseeking from friends and family, which may have implications for interpersonal support and
outcomes. Research and clinical approaches which incorporate biological as well as
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psychosocial factors may allow for more targeted and effective early interventions to address
lack of help-seeking and depression progression.
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1. Introduction
Depressive disorders and suicide are leading causes of morbidity worldwide, and their
magnitude is increasing (Whiteford et al., 2013). Early treatment reduces long term
impairment and is cost effective (Chisholm et al., 2004), however, large scale research
spanning numerous countries and including thousands of participants shows that most people
with major depressive disorder (MDD) do not receive treatment, even where effective
treatments are available (Kocsis et al., 2008; Thornicroft et al., 2017). Reasons for the undertreatment of depression are multi-factorial, however a major contributing factor is a
widespread reluctance of affected people to seek help (Kocsis et al., 2008; Thornicroft et al.,
2017). This refusal of, or withdrawal from, help has been termed help-negation (Clark and
Fawcett, 1992; Rudd et al., 1995) and is considered the most difficult barrier to the treatment
of depression (Han et al., 2006).

Previous research differentiates between help-seeking from informal sources including friends
and family, and formal sources including health care professionals and helplines. Most
previous studies of help-seeking for mental health problems have involved sub-clinical
student populations, who prefer seeking informal rather than formal help (Thomas et al.,
2014). A large-scale epidemiological study also found a general preference for informal
sources of help, and that the presence of depressive symptoms was associated with lower
intentions to seek help from family and friends, but no differences in formal help-seeking
intentions (Chin et al., 2015). It is important to consider informal supports, because friends
and family often facilitate treatment uptake and adherence in those with depressive symptoms
(Chin et al., 2015; Lindsey et al., 2010), and are important points of intervention in suicidal
behaviour (Barnes et al., 2002).
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It has traditionally been assumed that psychosocial factors underlie the widespread reluctance
of people to seek help for depression, and much research has examined the contributions of
factors such as stigma or embarrassment, however these seem to be only weakly negatively
associated with help-seeking (Clement et al., 2015). There is no clear evidence to demonstrate
that campaigns to increase treatment uptake through targeting stigma are successful
(Dumesnil and Verger, 2009; Henderson et al., 2013). Additionally, somewhat
counterintuitively, avoidance of treatment for depressive symptoms and psychological distress
is greater in individuals with greater psychopathology, stress levels, and suicidal ideation (e.g.
Carlton and Deane, 2000; Rudd et al., 1995; Sawyer et al., 2012). These factors lead us to
propose that help-negation might be related to biological, particularly neuroendocrine,
changes associated with the onset or progress of depression itself, which may be linked to
interpersonal difficulties and social withdrawal. To date there has been little examination of
relationships between help-seeking intentions, psychopathology and biological factors.
Overlooking the contribution of biological factors to help-negation may account for the suboptimal success of treatment uptake campaigns targeting psychosocial factors, and further
research is needed.

Cortisol, an output of the hypothalamus-pituitary-adrenal (HPA) axis, is a consistent
neurobiological indicator of stress, anxiety and depression (Levine et al., 2007). Prolonged
HPA hyperactivity through chronic stress is related to cognitive impairment (Lupien et al.,
2009), social withdrawal behaviour (Tops et al., 2005) and mood changes (Sapolsky, 2000).
Excess cortisol is a risk factor for developing MDD, and those with MDD often have
disturbances in diurnal cortisol rhythms, increased resistance to the feedback action of
glucocorticoids, higher basal levels and cortisol awakening response (Herbert, 2013). There
are indications that individuals with higher basal cortisol display both reduced closeness and
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that others desire to be less close to them (Ketay et al., 2017). Individuals with severe MDD
often show increased HPA-axis activity, which normalises during successful antidepressant
pharmacotherapy (Barden et al., 1995). Anti-depressants might elevate mood in MDD
through their long-term effects on HPA regulation (Barden et al., 1995). Depression-like
withdrawal and immobility can be induced in laboratory animals (Kulkarni and Dhir, 2007),
indicating that it can occur without language-based cognition, which implies a role for
physiological processes. Vegetative symptoms in depression may stem from processes that
evolved to preserve energy during insurmountable stress (Gilbert, 2001; Hart, 1988; Tsiouris,
2005). When placed in stressful situations from which escape is not possible, animals will
initially struggle and try to escape, but eventually develop immobility, a failure to persist in
active forms of coping with stressful stimuli. This passive behaviour is termed behavioural
despair, which is believed to be equivalent to depression (Porsolt et al., 1977), and it is
reversed with selective-serotonin reuptake inhibitors and with tricyclic antidepressants
(Kulkarni and Dhir, 2007). Cortisol levels may therefore be related to help-negation and to
depressive symptoms including vegetative symptoms, social withdrawal and cognitive
impairment. Relationships between cortisol levels, help-negation and symptom severity are
not yet known.

Oxytocin is a hormone which mediates a range of complex social behaviours relevant to
group-living mammals, including attachment, trust, and social support-seeking and in some
circumstances aggression (Heinrichs et al., 2009; Smith et al., 2017). Oxytocin is also
implicated in depression (Viero et al., 2010). It may therefore help to explain help-negation as
symptoms worsen in MDD. Oxytocin is a nonapeptide hormone which is synthesised in
hypothalamic nuclei and released directly into the bloodstream from axon terminals in the
posterior pituitary (MacDonald and MacDonald, 2010). Oxytocin is also transported from the
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hypothalamus to key brain areas, where it acts as a neurotransmitter (MacDonald and
MacDonald, 2010). Central effects of oxytocin include inhibition of stress-induced
hypothalamus-pituitary-adrenal (HPA) axis responsiveness, promotion of social behaviours,
and anti-depressant effects (Scantamburlo et al., 2007). Oxytocin is implicated in numerous
psychopathologies characterised by social discomfort, including depression, anxiety and
psychoses (Viero et al., 2010). Some symptoms of depression (social withdrawal, reduced eye
contact and low libido) may reflect blunted oxytocin function (Neumann, 2008). Helpseeking, particularly informally, usually involves interpersonal exchanges. Because oxytocin
is often inversely related to depressive symptoms, anxiety and stress (Scantamburlo et al.,
2007), and modulates social withdrawal and stress coping (Pompili et al., 2010), oxytocin
abnormalities may be related to help-negation in MDD. This possibility has yet to be
examined.

Given the clear involvement of biological processes in depression and withdrawal behaviour,
it is of interest to investigate their role in help-seeking intentions. Both cortisol and oxytocin
may represent modifiable risk factors for help-negation which potentially could be targeted in
novel interventions. The current study examined biological processes in connection with
symptom severity and help-seeking intentions in depressed and healthy individuals.
Based on previous research, it was predicted that:
1. Help-seeking intentions, particularly from informal sources, would be lower in
participants with MDD than healthy controls.
2. Cortisol will be negatively related to help-seeking intentions and perceived social
support and positively related to psychopathology, and the opposite patterns would be
observed for oxytocin.
3. Cortisol and oxytocin levels would be more closely related to informal than formal
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help-seeking intentions, as these involve more socially based interpersonal interactions.
4. Cortisol and oxytocin would both uniquely predict variance in help-seeking intentions,
after accounting for levels of psychopathology and perceived social support.
2. Methods
2.1 Participants
The protocol was approved by the local ethics committee, and all participants gave informed
written consent. Sixty-three adults were recruited who met the DSM-5 diagnostic criteria for
MDD, were not currently receiving treatment and had not recently had any treatment, along
with 60 healthy controls. Participants were recruited through advertisements in local media
and notices at the university. Exclusion criteria across groups included neurological disorders,
substance use disorders, and use of corticosteroid medication. Participants were screened
prior to the study with regard to exclusion criteria, and to ensure that depressed participants
likely met DSM-5 criteria for MDD and healthy controls had no significant mental health
problems. Depressed participants were also interviewed by a clinical psychologist on arrival
at the clinical trials unit to confirm that they met DSM-5 diagnostic criteria for major
depressive disorder, using the Mini International Neuropsychiatric Interview (Lecrubier et al.,
1997), and to ascertain treatment history and reasons for not being in treatment. Participants
received a store voucher of small value as a reimbursement for their time and inconvenience.
2.2 Measures
All participants completed the following measures: The Depression, Anxiety and Stress
Scales-21 (Lovibond and Lovibond, 1995), an overall measure of psychological distress
incorporating Depression, Anxiety and Stress subscales. The General Help-Seeking
Questionnaire-Vignette version (Wilson et al., 2005), a measure of intentions to seek help in
the event of mental health problems. Participants indicate on a 7-point Likert scale how likely
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they would be to seek help for depressive symptoms from specific informal (e.g. friends,
family, partner) and formal (e.g. doctor, psychologist, helpline) sources if they were
experiencing the same problems as the person in the vignette (1= Extremely unlikely, 3 =
Unlikely, 5 = Likely, 7 = Extremely likely). The Interpersonal Support Evaluation List-12
(Cohen et al., 1985), which yields a total score measuring perceived social support, and three
subscales reflecting perceived availability of Appraisal (advice or guidance), Belonging
(empathy, acceptance, concern), and Tangible social support (help or assistance, including
material and financial aid). The Brief Symptom Inventory (Derogatis and Melisaratos, 1983)
quantifies somatic and psychological symptoms of all major mental disorders. For this study
we used Item 9 “thoughts of ending own life” as a measure of suicidal ideation over the past
week. Additional psychometric and biometric measurements were also collected as part of a
larger study of MDD.

2.3 Blood collection and processing
Venepuncture occurred between 9-11 am. Blood (8mL) was collected from a vein in the
cubital fossa into tubes with EDTA then immediately placed on ice. Aprotinin was added
(25μL/mL blood) within 5 minutes of collection. Within 20 minutes of collection, blood was
centrifuged at 2800rpm and 4oC for 10 minutes, and then plasma was aliquoted and stored at
-80oC until analysis. Plasma cortisol and oxytocin were measured using a standard ELISA
method with detection at 450nm. Samples and standards were run in triplicate. The cortisol
assay had a sensitivity of 2.44 ng/mL with intra-assay and inter-assay variance of less than
9% and 10%, respectively. The oxytocin assay had a sensitivity of 15pg/mL with intra-assay
and inter-assay variance of less than 14% and 17%, respectively.
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2.4 Statistical analyses
A chi square test was used to compare sex distributions in the MDD versus healthy
control groups. Prior to analysis, data were examined for outliers and deviations from
normality. To correct for skew, the DASS, ISEL and BSI data were log transformed and
analyses were performed on both the untransformed and transformed data. The results were
found to be the same; hence only the untransformed data are reported. Prior to analyses, raw
cortisol and oxytocin values were log transformed to better approximate normal distributions.
Two-way Group (MDD, control) by Sex (male, female) ANOVAs were used to compare the
effects and interactions of clinical status and sex on each study variable. Pearson correlations
were used to assess relationships between the variables. Hierarchical multiple regressions
were employed to investigate whether cortisol and oxytocin accounted for unique variance in
help-seeking intentions beyond that explained by symptom severity and psychosocial
variables.

3. Results
3.1 Participant characteristics and psychometrics
Table 1 shows participant characteristics. Venepuncture was unsuccessful for two participants
and another participant did not complete all questionnaires, resulting in complete data sets for
60 controls and 60 participants with MDD. The groups did not differ significantly on age.
There were 35 females in each group, 25 males in the control group and 28 males in the
depressed group. The distribution of sexes between the groups was not statistically significant
X2 (2, N = 123) = 0.1, p = .76. Two-way ANOVAs with diagnostic Group (MDD, control) and
Sex (female, male) as between-group factors indicated that there were no significant
differences between males and females, and no Sex by Group interactions for any of the study
variables (P>.05 in all cases), hence all further analyses were run with data from both sexes
10

combined.

Participants with MDD had higher cortisol, lower oxytocin, and higher psychopathology
(DASS total, Depression, Anxiety and Stress) than controls (Table 1). Help-seeking intentions
were significantly lower in the MDD than control groups for informal sources and overall, but
did not differ significantly between groups for formal sources of help. Perceived social
support (ISEL-12) did not differ significantly between groups. Suicidal ideation (BSI Item 9)
was higher in the MDD than control groups.

Table 2 shows rank-ordered reasons given by depressed participants for not being in treatment
for their current MDD. The most commonly reported reasons were “side effects of
medication” and “unsure/ don’t know”.
3.2 Correlational analyses
Correlations between variables are shown in Table 3. Cortisol correlated positively with
psychopathology (DASS Total) and suicidal ideation (BSI Item 9) and negatively with helpseeking intentions from informal sources, and overall help-seeking intentions (GHSQ).
Oxytocin correlated positively with GHSQ help-seeking intentions from informal and all
sources overall. Psychopathology correlated with suicidal ideation and lower help-seeking
intentions from informal and overall sources. Help-seeking intentions from informal sources
correlated positively with perceived social support (ISEL-12) and inversely with suicidal
ideation. Help-seeking from formal sources correlated only with overall help-seeking
intentions. Overall help-seeking intentions correlated positively with perceived social support
and inversely with suicidal ideation. Perceived social support also correlated inversely with
suicidal ideation. The pattern of correlations between help-seeking intentions and other
measures was similar at the single item level to the subscale level, with no types of formal
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help (internet, telephone or face-to-face modes) correlating with hormones, and all types of
informal help (friends, relatives, partner) correlating with hormones. Therefore the results are
reported at the subscale rather than single-item level.

3.3 Hierarchical multiple regression
A hierarchical multiple regression was employed to investigate whether cortisol and oxytocin
accounted for unique variance in informal help-seeking intentions beyond that explained by
psychopathology (DASS Total and BSI suicidal ideation) and perceived social support (ISEL12; Table 4). Because help-seeking intentions from formal sources did not correlate
significantly with any other key study measures, a regression analysis was not performed for
formal help-seeking intentions. Also, while overall help-seeking intentions correlated with
cortisol and oxytocin levels, because only the informal help-seeking subscale was correlated
with hormonal measures, we did not perform a regression to investigate the value of
hormones in predicting overall help-seeking intentions.

For the regression analysis, psychopathology (DASS total), perceived social support (ISEL12) and suicidal ideation (BSI Item 9) were entered into the first step as control variables,
then cortisol and oxytocin levels were entered into the second step. In the first model which
included psychopathology, suicidal ideation and perceived social support, only
psychopathology (DASS; β = -.35, p <.001) emerged as a significant predictor of intentions to
seek informal help. When cortisol and oxytocin were entered into the second step of the
regression, both emerged as significant predictors of intentions to seek informal help, (β = .24, p =.01 and β = .21, p =.01, respectively) and psychopathology (DASS) was no longer a
significant independent predictor of informal help-seeking intentions. Overall, the second
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regression model was significant and accounted for 30% of the variance in intentions to seek
informal help, F = 9.68, p < .001, R2 = .30 (Table 4).
4. Discussion

We investigated whether biological factors are associated with the widespread avoidance of
help and treatment observed in depression. This represents a novel approach because previous
studies that have sought to understand help-negation for mental health problems have
concentrated on psychosocial issues and largely overlooked the possible role of biological
pathways in avoidance and withdrawal from help and treatment in MDD.

The hypothesis that help-seeking intentions, particularly from informal sources, would be
lower in participants with MDD than healthy controls was supported. Additionaly, the
severity of psychopathology and suicidal ideation correlated negatively with informal and
overall help-seeking intentions. These results are consistent with previous studies which have
found help-seeking intentions to be inversely related to the severity of mental health
problems, consistent with a help-negation effect (e.g. Carlton and Deane, 2000; Rudd et al.,
1995; Sawyer et al., 2012). As in previous studies, we found important distinctions between
help-seeking intentions from formal versus informal sources. Participants with MDD had
lower intentions than controls to seek help from informal sources, however there were no
between-group differences for formal help-seeking intentions, with mean responses in both
groups being mid-range between unlikely and likely for intentions to seek help. Our findings
with a clinically depressed sample are similar to previous ones in subclinical populations
which showed that the help-negation effect does not seem to apply strongly to formal sources
of help (Frost et al., 2017; Yakunina et al., 2010). Our results are also consistent with
previous evidence that depressive symptoms are associated with lower intentions to seek help
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from family and friends, but no effect on intentions to seek help from healthcare professionals
(Chin et al., 2015). Chin et al.(2015) interpreted their results in psychosocial terms, that a
depressed mood and negative thinking may make individuals reluctant to share their problems
with family and friends as they may feel burdensome or pessimistic.
In the current study we looked beyond psychosocial factors to investigate the novel
hypothesis that help-negation is related to neuroendocrine changes associated with
depression. Specifically, we predicted that cortisol would be positively related to
psychopathology and suicidal ideation and negatively related to perceived social support and
help-seeking intentions, and the opposite pattern would be observed for oxytocin. This
hypothesis was partially supported, as overall and informal help-seeking intentions were
related to these neuroendocrine markers, psychopathology, suicidal ideation and perceived
social support in the predicted directions. Our results indicated that cortisol was positively
associated with symptom severity and suicidal ideation and negatively associated with helpseeking intentions. This pattern of results indicates that cortisol may be a common factor
contributing to the help-negation effect, that is higher psychopathology and suicidal ideation
being related to lower help-seeking intentions, found in this and previous studies (e.g. Clark
and Fawcett, 1992; Rudd et al., 1995). Participants with MDD had higher mean morning
cortisol levels than control participants, consistent with previous research indicating
involvement of the HPA-axis in depression (Herbert, 2013). The correlation between suicidal
ideation and cortisol is consistent with studies which have found that disturbances in HPAaxis function and cortisol are linked to suicide (Jokinen and Nordström, 2009).

In our study, participants with MDD had lower oxytocin levels compared to controls. Similar
findings have been reported previously in small samples of depressed females (Ozsoy et al.,
2009; Yuen et al., 2014). Overall, however, very few previous studies have examined
14

oxytocin levels in MDD versus healthy controls, and findings are inconsistent (Massey et al.,
2016). This may be due to small sample sizes, heterogeneity in study designs, and other
methodological limitations (Massey et al., 2016). The current results suggest a need for
further research into relationships between depressive symptoms and oxytocin. Higher
oxytocin levels were associated with greater intentions to seek help from informal sources for
depressive symptoms. Additionally, perceived social support was positively correlated with
help-seeking from informal sources, indicating that those who expressed higher help-seeking
intentions from informal sources tended to perceive closer interpersonal bonds with friends
and family, as well as having higher oxytocin levels. Animal research indicates that oxytocin
plays key roles both in pro-social and anti-social behaviour (Smith et al., 2017). Oxytocin
buffers stress in the context of social behaviour, decreasing anxiety and helping animals to
overcome their natural avoidance of proximity, inhibiting defensive behaviour, and
facilitating approach behaviour (reviewed in Heinrichs et al., 2009). The current results
indicate that impairment in the oxytocinergic system in depression may be related to both
interpersonal difficulties and reduced help-seeking from friends and family.

The hypothesis that cortisol and oxytocin levels would be more closely related to informal
than formal help-seeking intentions was also supported, with only informal help-seeking
intentions correlating with neuroendocrine and psychosocial variables. Our results provide
novel evidence for separate processes being involved in informal versus formal help-seeking,
with the former being an interpersonal process related to psychosocial and neuroendocrine
function. Social and emotional difficulties are closely interwoven in depression (Rottenberg
and Gotlib, 2004). Stressful interpersonal relationships are risk factors for depression (Joiner,
2014), and in turn those providing informal support can become frustrated with the depressed
individual and reject them (Rottenberg and Gotlib, 2004). Interpersonal therapy (IPT) is
15

efficacious in reducing depressive symptoms through improving depressed individuals’ social
functioning, however the mechanisms through which it brings about changes remain largely
unknown (Rottenberg and Gotlib, 2004). The current results for help-seeking and perceived
social support, in the context of previous psychosocial literature, lead to the suggestion that
lower intentions to approach friends and family for help in MDD are related to interpersonal
difficulties observed in depression and that both may be underpinned by neuroendocrine
pathways which are involved in depression, stress and affiliation, modulated in part by
cortisol and oxytocin.

We also predicted that cortisol and oxytocin would both uniquely predict variance in helpseeking intentions after accounting for levels of psychopathology and perceived social
support. This hypothesis was supported for informal help-seeking intentions only, with both
oxytocin and cortisol levels being statistically significant unique contributors to help-seeking
intentions from informal sources, after accounting for symptom severity, perceived social
support and suicidal ideation. This provides the first evidence, to our knowledge, of
neuroendocrine involvement in predicting mental health help-seeking.

Cortisol and oxytocin did not correlate with each other, but were independently correlated
with other psychosocial variables and uniquely predicted help-seeking intentions. Previous
studies show variability in the correlation between oxytocin and cortisol across populations,
and laboratory tasks (Brown et al., 2016). Previous research indicates that oxytocin and
cortisol may correlate with psychometric measures independently, but not with each other
(Gordon et al., 2008). This has been interpreted to indicate that complex social behaviour is
shaped by both neuro-endocrine systems, with each independently predicting different
16

psychosocial measures (Feldman et al., 2007; Gordon et al., 2008).

The current results did not differ between males and females. Previous neuroendocrine
research often has uneven sex ratios (MacDonald and MacDonald, 2010), and while some
cortisol and oxytocin studies show sex effects or interactions, these are inconsistent
(MacDonald and MacDonald, 2010; Young and Korszun, 2010). A meta-analysis of cortisol
in MDD concluded that depression seems to elevate cortisol levels equally in men and women
(Stetler and Miller, 2011), consistent with our results. Females are more likely to experience
MDD than males (Angst et al., 2002; Kessler, 2003). The extent to which this is related to
biological vulnerabilities versus gender-related environments is unclear (Kessler, 2003).
Formal treatment-seeking is higher in females than males (Angst et al., 2002), however our
sample excluded people who were receiving or seeking any treatment and thus may have been
more homogeneous in this respect. Informal help-seeking levels may be similar between
males and females (Angst et al., 2002). Overall our results suggest an equivalent role of
cortisol and oxytocin in predicting help-seeking intentions for depressive symptoms in both
sexes.

While the neuroendocrine biomarkers provide some insight into biological pathways
associated with help-negation, we found no correlations between help-seeing intentions from
formal sources including health care professionals, and symptom severity, or psychosocial or
biological variables. Further, when participants with MDD were asked why they were not
seeking treatment, the most frequently given reasons were concerns about side effects of
medication or simply unsure/ no reason. We found little evidence of stigma being a barrier to
seeking professional treatment in the current sample. While the neuroendocrine results apply
only to informal help-seeking, they may still have implications for treatment uptake,
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adherence and outcomes in MDD. Help-seeking is not an isolated, rational action, but a
process which involves influence from individuals’ social network including friends and
family (Lindsey et al., 2010). Informal supports may help to confirm the presence of a
problem and influence help-seeking behaviour and recovery by providing emotional support,
reminding and helping the depressed person to attend appointments, and promoting adherence
to treatment (Chin et al., 2015; Lindsey et al., 2010). Informal sources of help have been
recognised as important gateways to treatment for mental health problems, and important
points of intervention in suicidal behaviour (Barnes et al., 2002). Our results are therefore
potentially clinically relevant and indicate a need for increased awareness of the role of
biological factors in withdrawal from informal support in depression, which may have
downstream effects on formal help-seeking.

The results of this study have implications for understanding depressive disorders, which
represent a large burden of untreated illness. Help-negation in MDD is a process associated
with poorer outcomes, long term impairment and suicide risk (Stanley et al., 2015).This study
provides preliminary evidence to support the development of a biopsychosocial model to
better understand the widespread reluctance of depressed individuals to seek help and
treatment. It is hoped that developing more comprehensive models to incorporate biological
processes including those mediated by oxytocin and cortisol may lead to novel interventions
which could reduce transitions to social withdrawal and suicidal behaviours in high risk
individuals.

If the widespread avoidance of help and withdrawal from family and friends in MDD can be
understood as a commonly occurring response to chronic stress and associated
neuroendocrine changes in MDD, it may facilitate problem-solving. There is some evidence
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that education about biological aetiological factors of depression is associated with increased
empowerment, motivation and preference for treatment, and decreased stigma (Goldstein and
Rosselli, 2003). Additionally, biological education about depression significantly increases
willingness to seek help, but de-stigmatisation education does not (Han et al., 2006). This is
possibly because biological education legitimises depression as a disease entity, which
increases motivation to solve the problem. Destigmatisation, on the other hand, reduces
people’s negative appraisals of the depressed individuals, but may not increase people’s
motivation to seek help (Han et al., 2006). Our results also suggest that iatrogenic concerns
may deserve more direct attention as barriers to seeking treatment for MDD.

Further research is needed to determine whether oxytocin administration might offer an
adjunctive treatment along the pathway between HPA axis activation, depressive symptoms
and withdrawal from help. Previous research indicates that social support and intranasal
oxytocin both show stress reduction and anxiolytic effects, which are stronger when
combined (Heinrichs et al., 2003). There have been no long term randomised controlled trials
(RCTs) of oxytocin administration in MDD. Given the evidence for the involvement of
oxytocin in the stress response, mood and interpersonal function, there is a need for RCTs of
oxytocin as an adjunctive treatment in MDD (Cochran et al., 2013).

4.1 Limitations and future directions

We analysed data at a single time point only, and further, longitudinal, studies are needed to
better understand the role of the HPA axis function in this context, and to determine causal
relationships between the variables. We quantified only two hormones and there are likely to
be complex interactions with other neurobiological pathways in depression that warrant
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further investigation. However, is a strength of the study that we employed a multi-systems
approach, examining markers of two endocrine systems in relation to psychosocial
responding, because multi-systems approaches may aid the construction of more meaningful
and complete models of biological systems involved in mental and physical health (Laurent et
al., 2016). Future research is needed to determine whether interventions aimed at changing
oxytocin or cortisol levels will have a positive effect on interpersonal relationships in people
with MDD and their help-seeking intentions. Although we included a measure of perceived
social support, it would also be of interest to examine other measures of interpersonal
functioning in relation to help-seeking and hormones. Finally, we measured help-seeking
intentions rather than actual help-seeking behaviours. Previous research indicates that the two
are correlated (e.g. Wilson et al., 2005), however intentions differ from actual help-seeking
behaviour, so further assessment of behaviours would be useful.
4.2 Conclusions
The results provide new information about interactions of psychosocial and neurobiological
factors which may help to explain why those with depressive symptoms are often reluctant to
seek help. More specifically, they indicate that help-seeking intentions from friends and
family are related to cortisol and oxytocin levels, symptom severity and perceived social
support, with the strongest predictors being cortisol and oxytocin. Lower help-seeking
intentions in MDD may be related to HPA axis activity, and dysfunctions in oxytocin
metabolism associated with depression. Further research is needed to ascertain whether
interventions aimed at changing hormone levels can improve interpersonal difficulties in
MDD. In the meantime, education regarding the involvement of biological factors in
reluctance to seek help for depressive symptoms and the importance of social support could
form the basis for new approaches to help and engage individuals with MDD, which go
beyond traditional psychosocial factors.

20

21

Tables

Table 1
Descriptive data and analyses of variance between depressed and healthy controls for
demographic, hormonal and psychometric study variables.

Variable

Depressed

Control

Mean (SD)

Mean (SD)

F

p

31.9 (14.55)

31.83
(10.98)

0.001

0.976

Age

Years

Cortisol

nmol/L

252.29
(102.63)

106.65
(64.53)

86.98

<.0001

Oxytocin

pg/mL

158 (140)

261.7
(158.97)

14.68

<.0001

Psychopathology DASS

Total

58.7 (26.51)

21 (18.32)

83.38

<.0001

Depression

23.21 (9.38)

6.2 (7.41)

123.76

<.0001

Anxiety

13.59 (10.65)

4.50 (5.57)

34.68

<.0001

Stress

21.90 (9.6)

10.30(7.97)

52.95

<.0001

Informal

2.94(1.29)

4.5(1.44)

39.97

<.0001

Formal

3.51(1.51)

3.41(1.32)

0.15

0.7

All sources

3.02 (.96)

3.64(.96)

12.57

0.001

Help-seeking intentions GHSQ

Social support ISEL-12

Total

28.95(7.14)

29.28
(2.52)

0.12

0.74

Suicidal Ideation BSI

Item 9

.76 (1.12)

.13 (.50)

15.91

<.0001

Note: DASS= Depression, Anxiety and Stress Scales; GHSQ = General Help-Seeking
Questionnaire; ISEL-12 = Interpersonal Support Evaluation List-12; BSI =Brief Symptom
Inventory.
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Table 2
Rank- ordered reasons given by depressed participants for
not seeking treatment.
Self-reported reasons by depressed
participants for not seeking treatment
Previously had side effects from medication

n (%)

Not sure/ no reason

14 (22)

Doesn’t want to take medications

9 (14)

Prefers to manage alone

6 (10)

Tried medication previously and it didn’t
work

5 (8)

Didn’t think treatment necessary/ waiting for
problems to go away

4 (6)

Psychology/counselling previously didn’t
work

4 (6)

No motivation for treatment

4 (6)

Thinks treatment won’t work

4 (6)

No time

2 (3)

Doesn’t trust health professionals

2 (3)

Cost of treatment

2 (3)

Prefers to use exercise to manage

2 (3)

Culturally unacceptable to seek treatment

1 (2)

Forgets to take medication

1 (2)

15 (24)

Note. The percentages do not sum to 100% because participants could give multiple reasons
for not being in treatment.
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Table 3
Pearson's Correlations for Study Variables

Variable
1.

Cortisol

2.

Oxytocin

3.

Psychopathology

4.

1

2

3

4

5

6

7

0.11

.49**

-0.14

Help-seeking Informal GHSQ

-.35**

.22*

-.47**

5.

Help-seeking Formal GHSQ

-0.02

0.02

-0.06

0.09

6.

Help-seeking All Sources GHSQ

-.24**

.19*

-.37**

.74**

.71**

7.

Perceived Social Support ISEL-12

0.02

0.07

-.26**

.25**

0.13

.27**

8.

Suicidal ideation

.33**

0.02

.55**

-.37**

-0.12

-.35**

DASS Total

BSI Item 9

-.37**

Note: DASS = Depression, Anxiety and Stress Scales; GHSQ = General Help-Seeking Questionnaire; ISEL-12 = Interpersonal Support Evaluation List-12;
BSI =Brief Symptom Inventory.
*p < .05, **p < .01
24

Table 4
Summary of Hierarchical Multiple Regression Analyses Predicting Help-Seeking Intentions from Informal Sources
Predictor
Step 1
Psychopathology DASS Total
Suicidal ideation BSI Item 9
Perceived social support ISEL12

R²

Adjusted R²

∆R²

.23

.21

.23**

B

SE B

β

p

-.02
-.21

.01
.17

-.35
-.13

<.01**
.20
.13

.04

.03

.11

Step 2
.30
.27
.07*
Psychopathology DASS Total
-.01
.01
-.20
.06
Suicidal ideation BSI Item 9
-.22
.17
-.13
.20
Perceived social support ISEL-12
.05
.03
.16
.07
Cortisol
-.003
.00
-.24
.01*
Oxytocin
.002
.00
.21
.01*
Note. SE = Standard Error, DASS = Depression, Anxiety and Stress Scales; GHSQ = General Help-Seeking Questionnaire; ISEL-12 =
Interpersonal Support Evaluation List-12; BSI =Brief Symptom Inventory.
*p < .05, **p < .01.
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